Product Pipeline Dynamic
Xenon is focused on advancing our ion channel neurology pipeline.
The products within our novel proprietary pipeline – including XEN496, XEN1101 and XEN007 – are aimed at treating neurological disorders, with a particular focus on epilepsy. We intend to pursue a variety of development strategies, such as those focused on using a “precision medicine” approach to address rare pediatric disorders, including KCNQ2 epilepsy, as well as those targeting broader patient populations, such as adult patients with focal epilepsy. We also have promising partnered products within our pipeline, such as NBI-921352 with Neurocrine Biosciences and FX301 with Flexion Therapeutics.
XEN1101
for Epilepsy
XEN1101
for MDD
Mount Sinai Collaboration
XEN496
for Epilepsy
NBI-921252
for Epilepsy
Partnered with Neurocrine Biosciences
NAV1.7 Inhibitors
for Pain
Partnered with Genentech
FX301
for Post-Operative Pain
Partnered with Flexion Therapeutics
